Home›Stock Screener›IOL Chemicals & Pharmaceuticals›Quarterly Results

IOL Chemicals & Pharmaceuticals Quarterly Results

Latest Quarter Net Profit
₹53 Cr
QMar 2026
Quarterly Results

IOL Chemicals & Pharmaceuticals quarterly results. In Mar 2026, IOL Chemicals & Pharmaceuticals (IOLCP) reported revenue ₹621 Cr and net profit ₹53 Cr — revenue +16.7% YoY. Review IOLCP PE ratio trends to evaluate earnings-based valuation against sector peers.

IOLCP Quarterly Results — Revenue, Profit & EPS Highlights

IOL Chemicals & Pharmaceuticals latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check IOL Chemicals & Pharmaceutical marketcap in USD to track the company's total market size over time.

  • Revenue of ₹621 Cr in Mar 2026 (-18.7% vs Jun 2026, +16.7% vs Mar 2025)
  • Net Profit of ₹53 Cr in Mar 2026 (-17.2% vs Jun 2026, +71.0% vs Mar 2025)
  • EBITDA of ₹94 Cr in Mar 2026 (-16.1% vs Jun 2026)
  • Operating Margin of 15.0% in Mar 2026 (+1.0pp vs Jun 2026)
  • Earnings Per Share of ₹1.81 in Mar 2026 (-17.4% vs Jun 2026)

IOL Chemicals & Pharmaceuticals Quarterly Results — Revenue, EBITDA, Net Profit & EPS

IOLCP quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 621 764 574 532 559 -18.7% 16.7%
Net Profit (₹ Cr) 53 64 30 31 34 - -
EBITDA (₹ Cr) 94 112 64 67 70 - -
EPS (₹) 1.81 2.19 1.02 1.07 1.16 - -
Operating Margin (%) 15.0% 14.0% 10.0% 12.0% 11.0% - -

IOLCP Share Price Trend — 1-Year Movement Across Quarterly Results

IOL Chemicals & Pharmaceuticals 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit IOL Chemicals & Pharmaceutical share price chart.

Profitability Ratios

Profit Margin 8.5%
EBITDA Margin 15.1%
Operating Margin 15.0%
ROE (Annual) 11.8%

Balance Sheet Highlights

Total Assets ₹2,587 Cr
Total Equity ₹1,799 Cr
Current Assets ₹1,228 Cr
Current Liabilities ₹98 Cr

Cash Flow Analysis

Operating Cash Flow ₹214 Cr
Investing Cash Flow ₹-198 Cr
Financing Cash Flow ₹-29 Cr
Net Cash Flow ₹-13 Cr

Current Market Data

Current Price ₹205.71
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 532
Sept 2025 574
Jun 2026 764
Mar 2026 621

Net Profit Trend (₹ Cr)

Mar 2025 31
Sept 2025 30
Jun 2026 64
Mar 2026 53

Operating Margin Trend (%)

Mar 2025 12.0%
Sept 2025 10.0%
Jun 2026 14.0%
Mar 2026 15.0%

IOLCP vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

IOL Chemicals & Pharmaceuticals latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores